← Back to Search

Educational Video for Lung Cancer Screening

N/A
Recruiting
Led By Amy R Leader, DrPH, MPH
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to endpoint, up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at using a video to educate people from minority and immigrant communities on lung cancer screening to reduce deaths from lung cancer.

Who is the study for?
This trial is for African American, Korean, or Chinese adults who are current/former smokers aged 50-80 with a significant smoking history. It aims to educate these communities about lung cancer and screening. Children, non-community members, those without a smoking history or prior lung cancer diagnosis/screening are excluded.
What is being tested?
The study tests the effectiveness of a culturally tailored educational video in promoting understanding and participation in lung cancer screening among vulnerable populations. The intervention includes discussions, media materials, interviews, and tests to measure impact.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to endpoint, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to endpoint, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To understand barriers and opportunities for engaging three culturally distinct populations in lung cancer screening.
Secondary study objectives
To develop three culturally tailored educational videos about lung cancer and the benefits of lung cancer screening
To test the impact of the videos on susceptibility to lung cancer, knowledge of lung cancer screening, and intentions to undergo lung cancer screening in a diverse sample of at-risk individuals.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm III (Aim 3) (video, test)Experimental Treatment2 Interventions
Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.
Group II: Arm II (Aim 2) (video, interview)Experimental Treatment2 Interventions
Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.
Group III: Arm I (Aim 1) (focus group)Experimental Treatment1 Intervention
Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~180

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
462 Previous Clinical Trials
175,418 Total Patients Enrolled
Amy R Leader, DrPH, MPHPrincipal InvestigatorThomas Jefferson University
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top